abstract |
Compounds with two fused bicyclic heteroaryl moieties of formula I and their pharmaceutical compositions, and methods of using them as leukotriene A 4 hydrolase (LTA 4 H) modulators and for the treatment of diseases, disorders and conditions mediated by LTA 4 H. |